Evidence map›Paper›PMID 38262962›Full record

ArticleBMC cancer2024

Correction: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.

Elif Şenocak Taşçı, Başak Oyan, Özlem Sönmez, Arda Ulaş Mutlu, Muhammed Mustafa Atcı, Abdullah Sakin, İrem Öner, Havva Yeşil Çınkır, Melek Karakurt Eryılmaz, Dilek Çağlayan and 23 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

33 authors at 20 institutions in 1 country.

Elif Şenocak TaşçıDepartment of Medical Oncology, Saglık Bilimleri University, Kanuni Sultan Süleyman Research and Training Hospital, Istanbul, Turkey. esenocak@gmail.com.
Başak OyanDepartment of Medicine, Acıbadem MAA University, Istanbul, Turkey.
Özlem SönmezDepartment of Medicine, Acıbadem MAA University, Istanbul, Turkey.
Arda Ulaş MutluDepartment of Medicine, Acıbadem MAA University, Istanbul, Turkey.
Muhammed Mustafa AtcıDepartment of Medical Oncology, Haseki Education and Research Hospital, Istanbul, Turkey.
Abdullah SakinDepartment of Medical Oncology, Medipol Bahçelievler Hospital, Istanbul, Turkey.
İrem ÖnerDepartment of Medical Oncology, Konya City Hospital, Konya, Turkey.
Havva Yeşil ÇınkırDepartment of Medical Oncology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey.
Melek Karakurt EryılmazMeram Faculty of Medicine, Department of Medical Oncology, Necmettin Erbakan University, Konya, Turkey.
Dilek ÇağlayanMeram Faculty of Medicine, Department of Medical Oncology, Necmettin Erbakan University, Konya, Turkey.
Onur Yazdan BalçıkDepartment of Medical Oncology, Mardin Education and Research Hospital, Mardin, Turkey.
Nail PaksoyDepartment of Medical Oncology, Tekirdağ Dr. İsmail Fehmi Cumalıoğlu City Hospital, Tekirdağ, Turkey.
Senem KarabulutDepartment of Medical Oncology, Şişli Kolan Hospital, Istanbul, Turkey.
Derya Kıvrak SalimDepartment of Medical Oncology, Antalya Education and Research Hospital, Antalya, Turkey.
Cemil BilirDepartment of Medical Oncology, Medical Park Hospital, Istanbul, Turkey.
Miraç ÖzenDepartment of Medical Oncology, Sakarya University Research and Education Hospital, Sakarya, Turkey.
Melike ÖzçelikDepartment of Medical Oncology, University of Health Sciences Umraniye Education and Research Hospital, Istanbul, Turkey.
Ali ArıcanDepartment of Medicine, Acıbadem MAA University, Istanbul, Turkey.
Baran AkagündüzDepartment of Medical Oncology, Binali Yıldırım University, Erzincan, Turkey.
Ali İnalDepartment of Medical Oncology, Mersin City Hospital, Mersin, Turkey.
Dinçer AydınDepartment of Medical Oncology, Derince Education and Research Hospital, Kocaeli, Turkey.
Leyla ÖzerDepartment of Medicine, Acıbadem MAA University, Istanbul, Turkey.
Ahmet GülmezDepartment of Medical Oncology, Adana City Hospital, Adana, Turkey.
Nazım Serdar TurhalDepartment of Medical Oncology, Anadolu Medical Center, Kocaeli, Turkey.
Selin Aktürk EsenDepartment of Medical Oncology, Ankara City Hospital, Ankara, Turkey.
Efnan AlgınDepartment of Medical Oncology, Ankara City Hospital, Ankara, Turkey.
Sinem AkbaşDepartment of Medical Oncology, Koç University Hospital, Istanbul, Turkey.
Yakup İriağaçDepartment of Medical Oncology, Namık Kemal University, Tekirdağ, Turkey.
Teoman ŞakalarDepartment of Medical Oncology, Necip Fazıl City Hospital, Kahramanmaraş, Turkey.
Çağlar ÜnalDepartment of Medical Oncology, Bilim University, Istanbul, Turkey.
Özlem ErDepartment of Medicine, Acıbadem MAA University, Istanbul, Turkey.
Şaban SeçmelerDepartment of Medical Oncology, Medical Park Bahçelievler Hospital, Istanbul, Turkey.
Mustafa BozkurtDepartment of Medicine, Acıbadem MAA University, Istanbul, Turkey.
Acıbadem University · TRMemorial Ankara Hospital · TRNecmettin Erbakan University · TRAnadolu University · TRAntalya Eğitim ve Araştırma Hastanesi · TRErzincan Binali Yıldırım University · TRGaziantep University · TRHaseki Eğitim ve Araştırma Hastanesi · TRIstanbul Bilim University · TRİstanbul Kanuni Sultan Süleyman Eğitim ve Araştırma Hastanesi · TRIstanbul Medipol University · TRKoç University · TRKonya Eğitim ve Araştırma Hastanesi · TRMardin Artuklu University · TRMemorial Sisli Hospital · TRMersin Üniversitesi · TRSakarya University · TRŞanlıurfa Mehmet Akif İnan Eğitim ve Araştırma Hastanesi · TRTekirdağ Namık Kemal University · TRÜmraniye Eğitim ve Araştırma Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38262962
PMCPMC10804792
OpenAlexW4391141869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.